How prepared are the US and its allies for a protracted conflict in Iran?
By Andrew Gawthorpe, Leiden University
If Israel and the US hoped their attack on Iran would force the country to capitulate quickly, they were wrong. Despite the death of the supreme leader,...
A Plan B for space? On the risks of concentrating national space power in private hands
By Svetla Ben-Itzhak, Johns Hopkins University
Private companies are no...
Related News: Iran war live updates: Trump says U.S. to offer insurance for Gulf shipping and escort tankers
President Donald Trump ordered the U.S. to provide risk insurance for...
Related News: Iran war live updates: Trump says U.S. to offer insurance for Gulf shipping and escort tankers
President Donald Trump ordered the U.S. to provide risk insurance for...
A Plan B for space? On the risks of concentrating national space power in private hands
By Svetla Ben-Itzhak, Johns Hopkins University
Private companies are no...
‘Destruction is not the same as political success’: US bombing of Iran shows little evidence of endgame strategy
By Farah N. Jan, University of Pennsylvania
Shortly...
The SaaSpocalypse Has Arrived…Or Has It?
Courtesy of Wade Slome, Investing Caffeine, www.Sidoxia.com
Well, the new month has started with a bang. Financial markets have not only...
US‑Israeli attack on Iran risks plunging the world into turmoil
By Arshin Adib-Moghaddam, SOAS, University of London
The US and Israel have launched extensive, coordinated attacks on...
Attack on Iran Underway
By Peter Zeihan
Peter Zeihan outlines a sweeping U.S. and Israeli military assault on Iran, describing it as a large-scale campaign aimed...
Anthropic CEO responds to Trump order, Pentagon clash
By CBS News
Anthropic CEO Dario Amodei sat down with CBS News for an exclusive interview, hours after...
Trump Orders Government to Stop Using Anthropic After Pentagon Standoff
The company had clashed with the military over how officials wanted to use its cutting-edge...
AI "hot takes" are becoming a market risk
By Eleanor Hawkins, Axios
Companies across sectors are confronting an increasingly unavoidable narrative: AI can replicate your business.
Why...
How Trump’s renewed tariff chaos will stifle investment around the world
By Sergi Basco, Universitat de Barcelona
After the US Supreme Court ruled against President Trump’s import...
Netflix Backs Out of Bid for Warner Bros., Paving Way for an Ellison Takeover
The move was a stunning development in the long-running corporate battle...
Anthropic Takes a Stand
The company is refusing to bow to the Pentagon’s demands.
By Will Gottsegen, The Atlantic
Earlier this week, Secretary of Defense Pete Hegseth sat...
AI’s growing appetite for power is putting Pennsylvania’s aging electricity grid to the test
Shixiang (Woody) Zhu, Carnegie Mellon University
The rapid growth of data centers...
Violent aftermath of Mexico’s ‘El Mencho’ killing follows pattern of other high‑profile cartel hits
By Angélica Durán-Martínez, UMass Lowell
The death of a major cartel boss...
Nvidia’s Quarterly Profit Hits $43 Billion on Strong A.I. Chip Sales
Total profit for the fiscal year was $120 billion, the company said. Three years...
What’s Happened Since the Supreme Court’s Tariff Ruling
After the Trump administration’s punishing tariffs were invalidated, the president said he would impose new tariffs using...
Mexico killed "El Mencho." Here's how and what we know about U.S. role
By Rebecca Falconer, Axios
Mexican security forces killed Nemesio Rubén Oseguera Cervantes, the country's...
At the beginning of February, the water level in the Baltic Sea dropped sharply. Experts tell Euronews it is a result of climate change. While global …
FDA’s abrupt flip-flop on Moderna’s mRNA flu shot highlights growing risks to drug-makers of investing in vaccines
By Ana Santos Rutschman, Villanova University
The Food and Drug...
Counter-drone technologies are evolving – but there’s no surefire way to defend against drone attacks
By Jamey Jacob, Oklahoma State University
When the Federal Aviation Administration...
Trump’s EPA decides climate change doesn’t endanger public health – the evidence says otherwise
By Jonathan Levy, Boston University; Howard Frumkin, University of Washington; Jonathan...
FDA rejects Moderna’s mRNA flu vaccine application - for reasons with no basis in the law
By Ana Santos Rutschman, Villanova University
The Food and Drug Administration...